Table 4. Model performance for prediction of 24-hour AKI and related outcomes.
AUC (95% CI) | ||||||
---|---|---|---|---|---|---|
Full Model | Demographic | Medications | Change in Creatinine | Procedures | Laboratory Studies | |
24-hour AKI | ||||||
YNHH validation set | 0.74 (0.73–0.74) | 0.65 (0.64–0.66) | 0.59 (0.59–0.60) | 0.61 (0.60–0.61) | 0.63 (0.62–0.63) | 0.69 (0.68–0.70) |
SRH | 0.69 (0.68–0.69) | 0.62 (0.61–0.63) | 0.60 (0.59–0.61) | 0.59 (0.58–0.60) | 0.59 (0.58–0.59) | 0.64 (0.63–0.65) |
BH | 0.76 (0.75–0.77) | 0.63 (0.62–0.65) | 0.62 (0.61–0.63) | 0.64 (0.63–0.65) | 0.60 (0.59–0.61) | 0.74 (0.73–0.75) |
Sustained AKI | ||||||
YNHH validation set | 0.77 (0.76–0.78) | 0.68 (0.67–0.69) | 0.62 (0.61–0.63) | 0.60 (0.59–0.61) | 0.66 (0.65–0.67) | 0.70 (0.69–0.72) |
SRH | 0.72 (0.71–0.73) | 0.65 (0.64–0.66) | 0.62 (0.61–0.63) | 0.57 (0.56–0.58) | 0.62 (0.61–0.63) | 0.65 (0.64–0.66) |
BH | 0.79 (0.78–0.80) | 0.65 (0.64–0.67) | 0.63 (0.62–0.65) | 0.63 (0.62–0.65) | 0.63 (0.61–0.64) | 0.76 (0.74–0.77) |
Renal Replacement Therapy | ||||||
YNHH validation set | 0.79 (0.73–0.85) | 0.79 (0.73–0.85) | 0.60 (0.52–0.67) | 0.51 (0.48–0.54) | 0.67 (0.61–0.74) | 0.73 (0.66–0.79) |
SRH | 0.85 (0.80–0.89) | 0.78 (0.73–0.83) | 0.61 (0.55–0.67) | 0.51 (0.46–0.57) | 0.62 (0.55–0.69) | 0.83 (0.78–0.88) |
BH | 0.78 (0.74–0.82) | 0.72 (0.66–0.78) | 0.56 (0.49–0.63) | 0.50 (0.47–0.54) | 0.62 (0.57–0.68) | 0.70 (0.64–0.75) |
Inpatient Mortality | ||||||
YNHH validation set | 0.69 (0.67–0.72) | 0.66 (0.64–0.69) | 0.59 (0.56–0.62) | 0.53 (0.51–0.54) | 0.67 (0.65–0.70) | 0.60 (0.57–0.63) |
SRH | 0.75 (0.73–0.77) | 0.74 (0.71–0.76) | 0.67 (0.64–0.69) | 0.53 (0.52–0.55) | 0.72 (0.69–0.75) | 0.63 (0.60–0.66) |
BH | 0.73 (0.71–0.75) | 0.68 (0.65–0.71) | 0.63 (0.60–0.66) | 0.56 (0.55–0.58) | 0.66 (0.63–0.70) | 0.65 (0.62–0.67) |
Abbreviations: AKI, acute kidney injury; AUC, area under the ROC curve; BH, Bridgeport Hospital; SRH, Saint Raphael's Hospital; YNHH, Yale New Haven Hospital.